Dong-A to launch biosimilar plant in Songdo
Published: 2011-10-04 06:57:00
Updated: 2011-10-04 06:57:00
Dong-A Pharmaceutical Co., the nation’s No.1 drug maker, said Thursday that it signed a memorandum of understanding (MOU) with Incheon Free Economic Zone (IFEZ) Authority to build and operate a a global biomedicine complex including a biosimilar plant in Songdo, some 30 kilometers west of Seoul n...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.